DDrare
Disease
Drug
Target Gene/Pathway
問合せ先
EN
97. 潰瘍性大腸炎
Ulcerative colitis
Clinical trials
/
Disease details
臨床試験数
:
2,630
/
薬物数
:
1,459
- (
DrugBank
:
265
) /
標的遺伝子数
:
144
-
標的パスウェイ数
:
202
Search
2 trials found
10
50
100
ALL
diseases per page:
Showing 1 to 2 of 2 diseases
Filter by
Reset
No.
TrialID
Date_
enrollment
Date_
registration
Public_title
Scientific_title
Condition
Intervention
Primary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
Phase
Countries
1
NCT02073526
(
ClinicalTrials.gov
)
May 2013
9/1/2014
Anti-TNF-alpha Trough Level Measurements in Inflammatory Bowel Disease
Anti-TNF-alpha Trough Level Measurements in Inflammatory Bowel Disease
Inflammatory Bowel Disease;Crohn's Disease;Ulcerative Colitis
Drug:
Infliximab
, adalimumab,
certolizumab pegol
Oslo University Hospital
NULL
Completed
18 Years
N/A
Both
1230
N/A
Norway
2
NCT01090154
(
ClinicalTrials.gov
)
December 1, 2010
15/3/2010
Certolizumab Pegol
for the Treatment of Moderate to Severe Ulcerative Colitis: An Open Label Study
Certolizumab Pegol
for the Treatment of Moderate to Severe Ulcerative Colitis: An Open Label Study
Ulcerative Colitis
Drug:
Cimzia
University of Washington
UCB Pharma;University of Pennsylvania
Completed
18 Years
75 Years
All
27
Phase 2
United States